- Home
- SNES
SNES
SenesTech Inc.
as 11-15-2024 4:00pm EST
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | PHOENIX |
| Market Cap: | N/A | IPO Year: | 2016 |
| Target Price: | $35.00 | AVG Volume (30 days): | 29.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -13.65 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.90 - $30.80 | Next Earning Date: | 11-12-2024 |
| Revenue: | $1,651,000 | Revenue Growth: | 38.16% |
| Revenue Growth (this year): | 91.45% | Revenue Growth (next year): | 101.31% |
Latest SenesTech Inc. News
SNES Breaking Stock News: Dive into SNES Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
SenesTech Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
GuruFocus.com
5 days ago
SenesTech Inc (SNES) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion
PR Newswire
5 days ago
SenesTech Announces Third Quarter 2024 Financial Results
PR Newswire
5 days ago
SenesTech Launches Evolve™ Rodent Birth Control on Walmart Marketplace
Zacks
10 days ago
QuidelOrtho (QDEL) Beats Q3 Earnings and Revenue Estimates
Insider Monkey
11 days ago
SenesTech (SNES): Why Small Positions May Not Be the Safe Bet You Think
PR Newswire
12 days ago
SenesTech to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
PR Newswire
17 days ago
Evolve™ Registered in Hong Kong; Offering a Revolutionary Non-Lethal Rodent Control Solution
Compare SNES vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SNES SenesTech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.